$ADIL

06.24.21 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]

Adial Pharmaceuticals #IPO Preview – $DNLI

Company: Adial Pharmaceuticals Symbol: ADIL Description: They are a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder using their lead investigational new drug product, AD04, a selective serotonin-3 antagonist. Shares: 1.4 million Price Range: $9.00-$11.00 Trade Date: 12/15 Underwriter(s): Joseph Gunnar & Co. Link to S-1/A[…]

Scroll to top
error: Content is protected !!